Seminars in Nuclear Medicine
Volume 31, Issue 3 , Pages 206-211 , July 2001

The role of nuclear medicine in monitoring treatment in skeletal malignancy

  • Gary J.R. Cook

      Affiliations

    • Department of Nuclear Medicine, Royal Marsden Hospital, Sutton, Surrey, England
    • Department of Nuclear Medicine, Guy's Hospital, London, England
    • Corresponding Author InformationAddress reprint requests to Gary J.R. Cook, MD, Department of Nuclear Medicine, Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, England.
    • ,
  • Ignac Fogelman

      Affiliations

    • Department of Nuclear Medicine, Royal Marsden Hospital, Sutton, Surrey, England
    • Department of Nuclear Medicine, Guy's Hospital, London, England

References 

  1. Galasko CSB. The anatomy and pathways of skeletal metastases. In: Weiss L, Gilbert AH editor. Bone Metastases. Boston, MA: GK Hall; 1981;
  2. Cook GJ, Houston S, Rubens R, et al. Detection of bone metastases in breast cancer by 18-FDG PET: Differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16:3375–3379
  3. Rubens RD. Bone metastases: Incidence and complications. In: Rubens RD, Munday GR editor. Cancer and the Skeleton. London: Martin Dunitz; 2000;
  4. Richards MA, Braysher S, Gregory WM, et al. Advanced breast cancer: Use of resources and cost implications. Br J Cancer. 1993;67:856–860
  5. Haywood JL, Carbone PP, Heuson JC, et al. Assessment of response to therapy in advanced breast cancer. Eur J Cancer. 1977;13:89–94
  6. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55:61–66
  7. Coombes RC, Dady P, Parsons C, et al. Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer. 1983;52:610–614
  8. Hortabagyi GN, Libshitz HI, Seabold JE. Osseous metastases of breast cancer. Clinical, biochemical, radiographic and scintigraphic evaluation of response to therapy. Cancer. 1984;55:577–582
  9. Palazzo S, Ligouri V, Molinari B. Is the carcino-embryonic antigen test a valid predictor of response to medical therapy in disseminated breast cancer. Tumori. 1986;72:515–518
  10. Schneider JA, Divgi CR, Scott AM, et al. Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer. J Nucl Med. 1994;35:1748–1752
  11. Johns WD, Garrick MB, Kaplan WD. Leuprolide therapy for prostate cancer. An association with scintigraphic flare on bone scan. Clin Nucl Med. 1990;15:485–487
  12. Rossleigh MA, Lovegrove FT, Reynolds PM, et al. The assessment of response to therapy in bone metastases from breast cancer. Aust NZ J Med. 1984;14:19–22
  13. Coleman RE, Mashiter G, Whitaker KB, et al. Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med. 1988;29:1354–1359
  14. Jacobson AF, Cronin EB, Stomper EC, et al. Bone scans with one or two new abnormalities in cancer patients with no known metastases: Frequency and serial scintigraphic behaviour of benign and malignant lesions. Radiology. 1990;175:229–232
  15. Condon BR, Buchanan R, Garvie NW, et al. Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging. Br J Radiol. 1981;54:18–23
  16. Galasko CSB. The pathophysiological basis for skeletal scintigraphy. In: Galasko CSB, Weber DA editor. Radionuclide Scintigraphy in Orthopaedics. Edinburgh: Churchill Livingstone; 1984;
  17. Greenberg EJ, Chu F, Dwyer AJ, et al. Effects of radiation therapy on bone lesions as measured by 47Ca and 85Sr local kinetics. J Nucl Med. 1972;13:747–751
  18. Knop J, Stritzke P, Langendorff G. New criteria for scintigraphic follow-up of bone metastases following radiotherapy. Results of functional scintigraphy using 99mTc-MDP. Nuklearmedizin. 1985;24:238–243
  19. Israel O, Gorenberg M, Frenkel A, et al. Local and systemic effects of radiation on bone metabolism measured by quantitative SPECT. J Nucl Med. 1992;33:1774–1780
  20. Bitran JD, Bekerman C, Desser RK. The predictive value of serial bone scans in assessing response to chemotherapy in advanced breast cancer. Cancer. 1980;45:1562–1568
  21. Erdi YE, Humm JL, Imbriaco M, et al. Quantitative bone metastases analysis based on image segmentation. J Nucl Med. 1997;38:1401–1406
  22. Pitt WR, Sharp PF. Comparison of quantitative and visual detection of new focal bone lesions. J Nucl Med. 1985;26:230–236
  23. Sundkvist GM, Ahlgren L, Lilja B, et al. Dynamic quantitative bone scintigraphy in patients with prostatic carcinoma treated by orchiectomy. Eur J Nucl Med. 1990;16:671–676
  24. Pollen JJ, Witzitum KF, Ashburn WL. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer. JAR Am J Roentgenol. 1984;142:773–776
  25. Levenson RM, Sauerbrunn BJL, Bates HR, et al. Comparative value of bone scintigraphy and radiography in monitoring tumour response in systemically treated prostatic cancer. Radiology. 1983;146:513–518
  26. Terris MK, Klonecke AS, McDougall IR, et al. Utilisation of bone scans in conjunction with prostate-specific antigen levels in the surveillance for recurrence of adenocarcinoma after radical prostatectomy. J Nucl Med. 1991;32:1713–1717
  27. Pollen JJ, Gerber K, Ashburn WL, et al. Nuclear bone imaging in metastatic cancer of the prostate. Cancer. 1981;47:2585–2594
  28. Sundqvist CMG, Ahlgren L, Lilja B, et al. Repeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchidectomy. Eur J Nucl Med. 1988;14:203–206
  29. Sumiya H, Tsuchiya H, Tomita K, et al. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy. J Nucl Med. 1997;38:501–506
  30. Sumiya H, Taki J, Tsuchiya H, et al. Midcourse thallium-201 scintigraphy to predict tumor response in bone and softtissue tumors. J Nucl Med. 1998;39:1600–1604
  31. Lam AS, Kettle AG, O'Doherty MJ, et al. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases. Nucl Med Commun. 1997;18:907–914
  32. Smith TA. FDG uptake, tumour characteristics and response to therapy: A review. Nucl Med Commun. 1998;19:97–105
  33. Shreve PD, Grossman HB, Gross MD, et al. Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology. 1996;199:751–756
  34. Kobayashi T, Ozaki T, Takeda Y, et al. Evaluation of the effect of preoperative chemotherapy in bone sarcomas. 99mTc-HMDP in 34 cases. Acta Orthop Scand. 1998;69:611–616
  35. Ramanna L, Waxman A, Binney G, et al. Thallium-201 scintigraphy in bone sarcoma: Comparison with gallium-67 and technetium-MDP in the evaluation of the chemotherapeutic response. J Nucl Med. 1990;31:567–572
  36. Van Laere K, Casier K, Uyttendaele D, et al. Technetium-99m-MDP scintigraphy and long-term follow-up of treated primary malignant bone tumours. J Nucl Med. 1998;39:1563–1569
  37. Hugenholtz EA, Piers DA, Kamps WA, et al. Bone scintigraphy in non-surgically treated Ewing's sarcoma at diagnosis and follow-up: Prognostic information of the primary tumour site. Med Pediatric Oncol. 1994;22:236–239
  38. Kostakoglu L, Panicek DM, Divgi CR, et al. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med. 1995;22:1232–1237
  39. Ohtomo K, Terui S, Yokoyama R, et al. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med. 1996;37:1444–1448
  40. Menendez LR, Fideler BM, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy. J Bone Joint Surg Am. 1993;75:1880–1881
  41. Garcia JR, Kim EE, Wong FCL, et al. Comparison of 18FDG-PET and 99mTc MIBI SPECT in evaluation of musculoskeletal sarcomas. J Nucl Med. 1996;37:1476–1479
  42. Jones DN, McCowage GB, Sostman HD, et al. Monitoring of neoadjuvant therapy response of soft tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med. 1996;37:1438–1444

PII: S0001-2998(01)80020-9

doi: 10.1053/snuc.2001.23527

Seminars in Nuclear Medicine
Volume 31, Issue 3 , Pages 206-211 , July 2001

Article Tools